about
Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials.Radiofrequency Ablation of Persistent Atrial Fibrillation: Diagnosis-to-Ablation Time, Markers of Pathways of Atrial Remodeling, and Outcomes.Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting.Prognostic Utility of Right Ventricular Free Wall Strain in Low Risk Patients After Orthotopic Heart Transplantation.Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials.Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials.Transvenous Lead Extraction at the Time of Cardiac Implantable Electronic Device Upgrade: Complexity, Safety and Outcomes.Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea.Atrial fibrillation post coronary artery bypass surgery: is there still a role for perioperative statins after STICS?Primary prevention implantable cardioverter defibrillator in patients with reduced ejection fraction: for ischemic or non-ischemic cardiomyopathy or both?Safety and efficacy of second-generation drug-eluting stents compared with bare-metal stents: An updated meta-analysis and regression of 9 randomized clinical trials.Ischemic postconditioning during primary percutaneous coronary intervention.Repeat ablation or medical management alone for recurrent arrhythmias after ablation of persistent atrial fibrillation.Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based Analysis.Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.Persistent Atrial Fibrillation Ablation With or Without Contact Force Sensing.Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.Relationship of mitral valve annulus plane and circumflex-right coronary artery plane: Implications for Transcatheter Mitral Valve Implantation.Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects.Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin IntoleranceCardiovascular safety of incretin-based therapy for type 2 diabetes: A meta-analysis of randomized trialsIncidence, Predictors, and Outcomes of Early Atrial Arrhythmias After Lung TransplantAn alarming trend: Change in the risk profile of patients with ST elevation myocardial infarction over the last two decadesIncretin-based therapy for type 2 diabetes: What have we learned from the meta-analyses?Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis"Atrial Fibrillation and Pulmonary Venous Electrical Conduction Recovery After Full Surgical Resection and Anastomosis of the Pulmonary Veins: Insights From Follow-Up and Ablation Procedures in Lung Transplant RecipientsInitial Experience With Non-Vitamin K Antagonist Oral Anticoagulants for Short-Term Anticoagulation After Left Atrial Appendage Closure DeviceCardiac Implantable Electronic Device Infections: Added Complexity and Suboptimal Outcomes With Previously Abandoned LeadsRelaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling
P50
Q30240823-D42EA7EF-FAF8-4650-80D1-42B7F1788B60Q37698465-DE1A3005-C21E-4203-B6FD-BBE8E2608542Q38668314-2CA823A6-AF4B-4441-B824-0F7783280581Q38705881-1E7DD13B-AF69-493F-888E-70A92AC42537Q38733131-0558FBB0-A23D-445A-8D1F-773CD31124D9Q38793234-7303ECF5-62FD-4B87-9EC4-F1EB71937D52Q38806425-6DB72EC8-4143-4C61-BA03-C9C9FE52AE89Q39190443-CB43CFBD-ED52-40FD-B62E-2344C98E1D73Q40144883-CF7C8316-4A4A-4FF1-85AE-C34CA7406AC0Q42331898-831B31A9-EB08-4E73-BDB2-AF8B13017508Q47133463-E89FB524-F313-4302-94D5-C578856B68CFQ47646584-0BB51B1B-0786-4EE4-A5C1-08E15471BCFBQ48122921-CD03BC2B-AEE7-40CB-9A52-FBA50B1F659CQ48167499-ACCB2FAD-F0B5-47FC-BC7B-25D8C338235CQ49722772-3A364D4B-A640-4AAC-BB12-AF79DC7A0B33Q50204515-4DCB1A31-533E-4554-9082-D8B0F4DD8378Q50849549-5101EC06-2C87-4C1C-A747-5205BB8CE90AQ50900626-A1E86C7D-1B1E-4ADD-BD9F-FD25277EFB1FQ51319005-F2E3F321-1F5F-4E22-A37D-01EC02D33FE4Q51319622-0E598253-84E5-466A-806C-1D1C652C3ACDQ53277338-C22111BF-2CD2-4E24-8418-B08FEDC83127Q56933941-D1601A59-E80E-4858-8E38-BCDC49A3C277Q62755825-7F52ADF2-FCB4-4BD9-8F95-A5A6B525E3AAQ62755911-17C0F606-AE66-45CD-BECB-D8A2C6253562Q63206003-D05E9D1E-2CF6-491F-9CE4-486F333F2DF1Q88190791-65B86EA8-51AF-4ECF-A713-58B6CD6994CAQ88344040-E07A6FC8-2C63-4AC4-A650-90C1A0EF0D9DQ88667901-B055A9B2-2E87-4115-990D-63282CE19EA8Q88668659-CF1144C8-5694-4442-A730-883C5A9085FEQ88668680-68D69E21-FE89-4470-9D51-DCE33942AC01Q91767798-DC199061-3F76-43C1-A59A-7312EA0C8296
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Amr Barakat
@en
Amr Barakat
@nl
type
label
Amr Barakat
@en
Amr Barakat
@nl
prefLabel
Amr Barakat
@en
Amr Barakat
@nl
P31
P496
0000-0001-6859-4616